Jose Carmona

2021 - Rubius Therapeutics

In 2021, Jose Carmona earned a total compensation of $659.2K as Chief Financial Officer at Rubius Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$200,250
Salary$450,000
Other$8,945
Total$659,195

Carmona received $450K in salary, accounting for 68% of the total pay in 2021.

Carmona also received $200.3K in non-equity incentive plan and $8.9K in other compensation.

Rankings

In 2021, Jose Carmona's compensation ranked 10,078th out of 12,415 executives tracked by ExecPay. In other words, Carmona earned more than 18.8% of executives.

ClassificationRankingPercentile
All
10,078
out of 12,415
19th
Division
Manufacturing
4,462
out of 5,501
19th
Major group
Chemicals And Allied Products
1,987
out of 2,371
16th
Industry group
Drugs
1,765
out of 2,092
16th
Industry
Biological Products, Except Diagnostic Substances
383
out of 449
15th
Source: SEC filing on March 30, 2022.

Carmona's colleagues

We found four more compensation records of executives who worked with Jose Carmona at Rubius Therapeutics in 2021.

2021

Pablo Cagnoni

Rubius Therapeutics

Chief Executive Officer

2021

Dannielle Appelhans

Rubius Therapeutics

Chief Operating Officer

2021

Maiken Keson-Brookes

Rubius Therapeutics

Chief Legal Officer

2021

Laurence Turka

Rubius Therapeutics

Chief Scientific Officer

News

You may also like